Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment
author
statement of authorship
Linnéa Tyrberg, Fanny Andersson, Fredrik Uhlin, Thomas Hellmark, Mårten Segelmark
publisher
journal volume number month
vol. 39, 1
year of publication
pages
p. 45-54
ISSN
0931-0509
notes
Bibliogr.: 35 ref
Open Access
Open Access
scientific publication
teaduspublikatsioon
language
inglise
subject term
keyword
autoantibody-mediated renal disease
double positivity
epitope specificity
subclass distribution
category (general)
category (sub)
TalTech department
Tyrberg, L., Andersson, F., Uhlin, F., Hellmark, T., Segelmark, M. Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment // Nephrology Dialysis Transplantation (2024) vol. 39, 1, p. 45-54. https://doi.org/10.1093/ndt/gfad132